Research Article

USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration

Figure 3

Correlation between six-USP expression and the clinicopathological features of pancreatic ductal adenocarcinoma (PDAC) patients in GEO datasets. (a) The comparison between head () and body/tail () of PDAC from GSE62165. (b) The expression levels of six-USPs via the comparison between T1-T2 () and T3-T4 () in GSE21501 dataset. (c) The expression levels of six- USPs in PDAC patients with/without lymphatic metastasis (N1/N0, 73 vs. 28) in GSE21501 dataset. (d) The mRNA levels of six-USPs in different differentiated degrees of PDAC (G1-G2 vs. G3-G4, 37 vs. 31) using GSE62452 dataset. (e) The transcriptional levels of six-USPs in different pancreatic precancerous lesions compared with normal pancreatic tissues using GSE19650 dataset. Normal (), IPMA (), IPMC (), and IPMN (). The code behind the gene is the gene ID in different GEO datasets. , , and . n.s.: not significant difference.
(a)
(b)
(c)
(d)
(e)